NCT07111806View on ClinicalTrials.gov

Intravenous Tirofiban After Delayed Thrombolysis in Stroke

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

852

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 1, 2028

Study Completion Date

March 1, 2029

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Tirofiban

Tirofiban is administered as a loading dose and continuous intravenous infusion as soon as possible after the randomization.

DRUG

Placebo

Matched placebo will be infused in a similar fashion.

Trial Locations (1)

510120

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER